GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (NYSE:TFX) » Definitions » Cyclically Adjusted Price-to-FCF

TFX (Teleflex) Cyclically Adjusted Price-to-FCF : 12.62 (As of Jul. 09, 2025)


View and export this data going back to 1972. Start your Free Trial

What is Teleflex Cyclically Adjusted Price-to-FCF?

As of today (2025-07-09), Teleflex's current share price is $119.68. Teleflex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $9.48. Teleflex's Cyclically Adjusted Price-to-FCF for today is 12.62.

The historical rank and industry rank for Teleflex's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TFX' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 12.31   Med: 39.04   Max: 72.89
Current: 12.31

During the past years, Teleflex's highest Cyclically Adjusted Price-to-FCF was 72.89. The lowest was 12.31. And the median was 39.04.

TFX's Cyclically Adjusted Price-to-FCF is ranked better than
83.87% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 35.68 vs TFX: 12.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Teleflex's adjusted free cash flow per share data for the three months ended in Mar. 2025 was $0.938. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $9.48 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Teleflex Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Teleflex's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex Cyclically Adjusted Price-to-FCF Chart

Teleflex Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.88 44.93 31.36 28.90 19.06

Teleflex Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.54 23.74 27.07 19.06 14.58

Competitive Comparison of Teleflex's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Teleflex's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teleflex's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Teleflex's Cyclically Adjusted Price-to-FCF falls into.


;
;

Teleflex Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Teleflex's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=119.68/9.48
=12.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Teleflex's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.938/134.9266*134.9266
=0.938

Current CPI (Mar. 2025) = 134.9266.

Teleflex Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 1.042 100.684 1.396
201509 1.078 100.392 1.449
201512 2.279 99.792 3.081
201603 1.207 100.470 1.621
201606 2.157 101.688 2.862
201609 2.181 101.861 2.889
201612 1.934 101.863 2.562
201703 1.669 102.862 2.189
201706 1.754 103.349 2.290
201709 2.247 104.136 2.911
201712 1.810 104.011 2.348
201803 1.518 105.290 1.945
201806 1.584 106.317 2.010
201809 2.208 106.507 2.797
201812 2.350 105.998 2.991
201903 0.858 107.251 1.079
201906 1.354 108.070 1.690
201909 2.205 108.329 2.746
201912 2.729 108.420 3.396
202003 -0.663 108.902 -0.821
202006 2.667 108.767 3.308
202009 1.773 109.815 2.178
202012 3.530 109.897 4.334
202103 1.925 111.754 2.324
202106 2.883 114.631 3.393
202109 3.578 115.734 4.171
202112 3.837 117.630 4.401
202203 1.032 121.301 1.148
202206 0.427 125.017 0.461
202209 2.584 125.227 2.784
202212 1.518 125.222 1.636
202303 1.316 127.348 1.394
202306 1.449 128.729 1.519
202309 3.747 129.860 3.893
202312 2.350 129.419 2.450
202403 1.531 131.776 1.568
202406 1.193 132.554 1.214
202409 4.463 133.029 4.527
202412 3.657 133.157 3.706
202503 0.938 134.927 0.938

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Teleflex  (NYSE:TFX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Teleflex Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Teleflex's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Teleflex Business Description

Traded in Other Exchanges
Address
550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Executives
Stuart A Randle director 585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Cameron P Hicks officer: Vice President, Global HR 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Liam Kelly officer: EVP & President, International IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000
Thomas E Powell officer: Senior Vice President & CFO C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717
Jaewon Ryu director 950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203
Neena M Patil director JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304
Andrew A Krakauer director CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Klasko Stephen K. M.d. director 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468
Jay White officer: VP & Pres, Global Commercial 3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560
Daniel V. Logue officer: VP, Gen Counsel & Secretary 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
John Deren officer: VP & Chief Accounting Officer 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
James J Leyden officer: VP, General Counsel, Secretary C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014
James Winters officer: Vice President, Mfg and Supply 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Mario Wijker officer: Vice President, QARA 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Benson Smith director C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976